BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 23722670)

  • 1. miR-9 functions as a tumor suppressor in ovarian serous carcinoma by targeting TLN1.
    Tang H; Yao L; Tao X; Yu Y; Chen M; Zhang R; Xu C
    Int J Mol Med; 2013 Aug; 32(2):381-8. PubMed ID: 23722670
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of ovarian cancer progression by microRNA-187 through targeting Disabled homolog-2.
    Chao A; Lin CY; Lee YS; Tsai CL; Wei PC; Hsueh S; Wu TI; Tsai CN; Wang CJ; Chao AS; Wang TH; Lai CH
    Oncogene; 2012 Feb; 31(6):764-75. PubMed ID: 21725366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The hypoxia-related microRNA miR-199a-3p displays tumor suppressor functions in ovarian carcinoma.
    Kinose Y; Sawada K; Nakamura K; Sawada I; Toda A; Nakatsuka E; Hashimoto K; Mabuchi S; Takahashi K; Kurachi H; Lengyel E; Kimura T
    Oncotarget; 2015 May; 6(13):11342-56. PubMed ID: 25839163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RhoC is a major target of microRNA-93-5P in epithelial ovarian carcinoma tumorigenesis and progression.
    Chen X; Chen S; Xiu YL; Sun KX; Zong ZH; Zhao Y
    Mol Cancer; 2015 Feb; 14(1):31. PubMed ID: 25649143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-222-3p/GNAI2/AKT axis inhibits epithelial ovarian cancer cell growth and associates with good overall survival.
    Fu X; Li Y; Alvero A; Li J; Wu Q; Xiao Q; Peng Y; Hu Y; Li X; Yan W; Guo K; Zhou W; Wang Y; Liu J; Zhang Y; Mor G; Wen J; Yin G
    Oncotarget; 2016 Dec; 7(49):80633-80654. PubMed ID: 27811362
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-181b promotes ovarian cancer cell growth and invasion by targeting LATS2.
    Xia Y; Gao Y
    Biochem Biophys Res Commun; 2014 May; 447(3):446-51. PubMed ID: 24735543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-133b inhibits proliferation and invasion of ovarian cancer cells through Akt and Erk1/2 inactivation by targeting epidermal growth factor receptor.
    Liu X; Li G
    Int J Clin Exp Pathol; 2015; 8(9):10605-14. PubMed ID: 26617770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-155 is a novel suppressor of ovarian cancer-initiating cells that targets CLDN1.
    Qin W; Ren Q; Liu T; Huang Y; Wang J
    FEBS Lett; 2013 May; 587(9):1434-9. PubMed ID: 23523916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miR-141 is a key regulator of renal cell carcinoma proliferation and metastasis by controlling EphA2 expression.
    Chen X; Wang X; Ruan A; Han W; Zhao Y; Lu X; Xiao P; Shi H; Wang R; Chen L; Chen S; Du Q; Yang H; Zhang X
    Clin Cancer Res; 2014 May; 20(10):2617-30. PubMed ID: 24647573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Expression and significance of microRNAs in the p53 pathway in ovarian cancer cells and serous ovarian cancer tissues].
    Zhang Q; He XJ; Ma LP; Li N; Yang J; Cheng YX; Cui H
    Zhonghua Zhong Liu Za Zhi; 2011 Dec; 33(12):885-90. PubMed ID: 22340095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-613 inhibited ovarian cancer cell proliferation and invasion by regulating KRAS.
    Fu X; Cui Y; Yang S; Xu Y; Zhang Z
    Tumour Biol; 2016 May; 37(5):6477-83. PubMed ID: 26631045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Programmed cell death 4 and microRNA 21 inverse expression is maintained in cells and exosomes from ovarian serous carcinoma effusions.
    Cappellesso R; Tinazzi A; Giurici T; Simonato F; Guzzardo V; Ventura L; Crescenzi M; Chiarelli S; Fassina A
    Cancer Cytopathol; 2014 Sep; 122(9):685-93. PubMed ID: 24888238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miR-335 represents an invasion suppressor gene in ovarian cancer by targeting Bcl-w.
    Cao J; Cai J; Huang D; Han Q; Yang Q; Li T; Ding H; Wang Z
    Oncol Rep; 2013 Aug; 30(2):701-6. PubMed ID: 23708561
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-7 inhibits tumor growth and metastasis by targeting the phosphoinositide 3-kinase/Akt pathway in hepatocellular carcinoma.
    Fang Y; Xue JL; Shen Q; Chen J; Tian L
    Hepatology; 2012 Jun; 55(6):1852-62. PubMed ID: 22234835
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-218 inhibits cell migration and invasion in renal cell carcinoma through targeting caveolin-2 involved in focal adhesion pathway.
    Yamasaki T; Seki N; Yoshino H; Itesako T; Hidaka H; Yamada Y; Tatarano S; Yonezawa T; Kinoshita T; Nakagawa M; Enokida H
    J Urol; 2013 Sep; 190(3):1059-68. PubMed ID: 23454155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-133a functions as a tumor suppressor and directly targets FSCN1 in pancreatic cancer.
    Qin Y; Dang X; Li W; Ma Q
    Oncol Res; 2013; 21(6):353-63. PubMed ID: 25198665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MiR-718 represses VEGF and inhibits ovarian cancer cell progression.
    Leng R; Zha L; Tang L
    FEBS Lett; 2014 Jun; 588(12):2078-86. PubMed ID: 24815691
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Micro RNA miR-1303 Promotion of Proliferation, Migration and Invasion of Human Liver Cancer Cells Is Enhanced by Low Talin 1 (TLN1) Expression.
    Huang J; Xi Q; Xiong J; Peng H; Yang H; Sun YU; Hoffman RM
    Anticancer Res; 2022 Oct; 42(10):4715-4725. PubMed ID: 36192016
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High expression of ENPP1 in high-grade serous ovarian carcinoma predicts poor prognosis and as a molecular therapy target.
    Wang H; Ye F; Zhou C; Cheng Q; Chen H
    PLoS One; 2021; 16(2):e0245733. PubMed ID: 33635867
    [TBL] [Abstract][Full Text] [Related]  

  • 20. microRNA-125a-3p reduces cell proliferation and migration by targeting Fyn.
    Ninio-Many L; Grossman H; Shomron N; Chuderland D; Shalgi R
    J Cell Sci; 2013 Jul; 126(Pt 13):2867-76. PubMed ID: 23606749
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.